Women lose bone faster after menopause, and that's exactly the group most vitamin K2 trials have studied. Here's what those studies found, what they didn't, and how K2 fits with the basics.
Written by Vita Globe Editorial Team | Reviewed against NIH guidance and randomized controlled trials
What are the benefits of vitamin K2 for women?
The best evidence is for bone in postmenopausal women. In a three-year randomized trial, 180 mcg of MK-7 a day slowed age-related loss of bone density at the lower spine and femoral neck compared with placebo[1]. A 2022 meta-analysis of 16 trials found K2 improved lumbar spine bone density[2]. But results aren't consistent: a one-year trial in early-menopausal women found no effect on bone loss[3].
Caveat: K2 is not a treatment for osteoporosis. If you've been diagnosed with low bone density, work with your doctor on proven therapies.
Sources: Knapen et al., 2013 · Ma et al., 2022 · Emaus et al., 2010 · Verified 2026-09-27
In this article
Why is vitamin K2 research focused on women?
After menopause, falling estrogen speeds up bone loss, which is why postmenopausal women are at higher risk of osteoporosis. Vitamin K helps activate osteocalcin, a protein made by bone-building cells that binds calcium[4]. That's the biological reason researchers have tested K2 in this group.
K2 isn't a women-only nutrient, and the Adequate Intake for vitamin K is 90 mcg a day for adult women[4]. There's no separate K2 target.
What do the bone studies show?
The encouraging results. In the Knapen trial, 244 healthy postmenopausal women took 180 mcg of MK-7 or placebo for three years. The MK-7 group had less decline in bone mineral density at the lower spine and femoral neck, better bone strength measures and less loss of vertebral height in the lower thoracic spine. There was no difference at the total hip[1].
An earlier three-year trial using a high dose of MK-4 found improved hip bone strength indices in postmenopausal women[5]. A 2022 meta-analysis of 16 randomized trials (6,425 participants) reported improved lumbar spine bone density and fewer fractures with K2, with no significant adverse effects[2].
The neutral results. In a Norwegian trial, 334 women one to five years past menopause took 360 mcg of MK-7 or placebo for a year. MK-7 improved vitamin K status markers, but bone loss rates didn't differ[3]. Shorter duration may explain part of the difference.
The honest summary
- Several trials suggest K2 may help slow bone loss after menopause.
- Others found no effect, so the evidence is promising but mixed.
- Benefits, where seen, took years to show up.
Does K2 help women's heart health?
In the same three-year trial, MK-7 improved measures of arterial stiffness, particularly in women who started with stiffer arteries[6]. Arterial stiffness is a marker linked to cardiovascular risk, but improving a marker isn't the same as preventing heart disease. We cover this in vitamin K2 and heart health.
How does K2 fit with the bone-health basics?
K2 is, at most, a supporting player. The foundations for bone health are adequate calcium and vitamin D, weight-bearing and resistance exercise, not smoking and limiting alcohol. Ask your doctor whether a bone density scan makes sense for you.
For how calcium, D3 and K2 work together, see Calcium, Vitamin D3 & K2: The Bone-Support Trio Explained, and for the pairing question, taking D3 and K2 together.
What should women know before taking K2?
- Warfarin: vitamin K counteracts it. Don't start K2 without your doctor's okay[4]. See vitamin K2 and blood thinners.
- Pregnancy and nursing: talk to your provider before adding any supplement.
- Osteoporosis medications: K2 is not a substitute. Ask your doctor whether it makes sense alongside your treatment.
Our option
Vita Globe Vitamin K2 Gummies
Our Vitamin K2 Gummies are a simple way to add K2 to a bone-support routine alongside calcium and vitamin D. They're raspberry-flavored, with a suggested use of 2 gummies once daily, and they're vegan-friendly, gluten-free and non-GMO, made without artificial colors or flavors. Like every Vita Globe product, they're tested by an independent third-party lab.
Frequently asked questions
Is vitamin K2 good for menopause?
It doesn't treat menopause symptoms. The research interest is bone: some trials in postmenopausal women found MK-7 slowed bone density loss[1], while others found no effect[3].
Can vitamin K2 reverse osteoporosis?
No. Trials show, at best, slower bone loss, not reversal. Osteoporosis needs a treatment plan from your doctor.
How much K2 do women need?
There's no K2-specific recommendation. The Adequate Intake for all vitamin K is 90 mcg a day for women[4]. Trials have used 180 mcg of MK-7 daily[1].
Is vitamin K2 safe during pregnancy?
Vitamin K is essential in pregnancy, but talk to your healthcare provider before taking any new supplement while pregnant or nursing.
Sources
- Knapen MHJ, Drummen NE, Smit E, Vermeer C, Theuwissen E. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int. 2013;24(9):2499-2507. doi:10.1007/s00198-013-2325-6
- Ma ML, Ma ZJ, He YL, et al. Efficacy of vitamin K2 in the prevention and treatment of postmenopausal osteoporosis: a systematic review and meta-analysis of randomized controlled trials. Front Public Health. 2022;10:979649. doi:10.3389/fpubh.2022.979649
- Emaus N, Gjesdal CG, Almås B, et al. Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial. Osteoporos Int. 2010;21(10):1731-1740. doi:10.1007/s00198-009-1126-4
- Office of Dietary Supplements, National Institutes of Health. Vitamin K: Fact Sheet for Health Professionals. Updated March 29, 2021. ods.od.nih.gov
- Knapen MHJ, Schurgers LJ, Vermeer C. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int. 2007;18(7):963-972. doi:10.1007/s00198-007-0337-9
- Knapen MHJ, Braam LAJLM, Drummen NE, Bekers O, Hoeks APG, Vermeer C. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. Thromb Haemost. 2015;113(5):1135-1144. doi:10.1160/TH14-08-0675
About the Vita Globe Editorial Team
The Vita Globe Editorial Team researches and writes our wellness content, working from peer-reviewed research, systematic reviews and guidance from bodies such as the NIH and the FDA. We cite our sources inline and update articles when the evidence changes.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for medical advice. Talk to your healthcare provider before starting any new supplement, particularly if you are pregnant, nursing, taking medication, or caring for a child.
